Machine learning identifies inflammation-related diagnostic biomarkers for primary myelofibrosis with clinical

Rumeng Li1, Qinmei Han1, Tian Zeng1

  • 1Department of Haematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.

Scientific Reports
|November 20, 2025
PubMed

Insights

A new diagnostic model using three inflammation-related genes (IRGs) can help detect primary myelofibrosis (PMF). This model shows high accuracy in identifying PMF, offering a potential noninvasive tool for early diagnosis and risk assessment.

Area of Science:

  • Hematology
  • Oncology
  • Genomics

Background:

  • Primary myelofibrosis (PMF) is a complex bone marrow disorder where inflammation plays a key role in its progression.
  • Currently, no established diagnostic model effectively utilizes inflammation-related genes for PMF diagnosis or risk stratification.

Purpose of the Study:

  • To identify specific inflammation-related genes (IRGs) with diagnostic and prognostic value for primary myelofibrosis (PMF).
  • To develop and validate a predictive model for PMF using machine learning approaches.

Main Methods:

  • Transcriptomic data from the Gene Expression Omnibus (GEO) database were analyzed to identify differentially expressed genes (DEGs).
  • Machine learning algorithms, including LASSO and random forest, were employed to select key hub genes.
  • A nomogram model was constructed using selected genes and validated using independent datasets and local sequencing data.

Main Results:

  • Three genes (HBEGF, TIMP1, PSEN1) were identified with significant expression differences between PMF patients and healthy individuals.
  • A nomogram based on these three genes demonstrated high diagnostic accuracy (AUC=0.994) in the initial cohort and was validated externally (AUC=0.807, AUC=0.982).
  • Enrichment analyses revealed associations with cancer and immune pathways, and model genes correlated with immune cell infiltration and function.

Conclusions:

  • A robust three-gene diagnostic model for PMF based on inflammation-related genes has been developed and validated.
  • This model offers a promising noninvasive molecular tool for the auxiliary diagnosis and risk assessment of primary myelofibrosis.

Related Concept Videos